Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bc63b13ff7b51c0b5222bf330e6aea9b4> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bc63b13ff7b51c0b5222bf330e6aea9b4 NCIT_P378 "NCI" @default.
- Bc63b13ff7b51c0b5222bf330e6aea9b4 type Axiom @default.
- Bc63b13ff7b51c0b5222bf330e6aea9b4 annotatedProperty IAO_0000115 @default.
- Bc63b13ff7b51c0b5222bf330e6aea9b4 annotatedSource NCIT_C156681 @default.
- Bc63b13ff7b51c0b5222bf330e6aea9b4 annotatedTarget "A recombinant antibody derivative composed of tri-specific T-cell activating construct (TriTAC) directed against the human tumor-associated antigen (TAA) prostate-specific membrane antigen (PSMA; FOLH1) and the CD3 antigen found on T-lymphocytes and an albumin-binding domain, with potential immunostimulating and antineoplastic activities. Upon administration, PSMA/CD3 tri-specific T-cell antibody construct HPN424 targets and binds PSMA on tumor cells and CD3 on cytotoxic T-lymphocytes (CTLs), thereby bringing PSMA-expressing tumor cells and CTLs together, which results in the CTL-mediated cell death of PSMA-expressing tumor cells. The albumin-binding domain targets and binds to serum albumin, thereby extending the serum half-life of HPN424. PSMA is overexpressed on the surface of metastatic and hormone-refractory prostate tumor cells." @default.